The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung Cancer
Clinical trial NCT07638878 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07638878
- Sponsor
- Guangzhou Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-06
- Primary completion
- 2027-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.